T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication.
about
The Role of Imaging in Aortic Valve DiseasePrediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis.Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carriers.T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitidesCardiac MRI evaluation of myocardial disease.Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.Towards accurate and precise T 1 and extracellular volume mapping in the myocardium: a guide to current pitfalls and their solutions.Recent advances in the noninvasive strategies of cardiac amyloidosis.Electrocardiographic Impact of Myocardial Diffuse Fibrosis and Scar: MESA (Multi-Ethnic Study of Atherosclerosis).T1 Mapping for Myocardial Fibrosis by Cardiac Magnetic Resonance Relaxometry-A Comprehensive Technical Review.Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.Myocardial iodine concentration measurement using dual-energy computed tomography for the diagnosis of cardiac amyloidosis: a pilot study.Age and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR.Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for CardiovascularA prospective study examining the role of myocardial Fibrosis in outcome following mitral valve repair IN DEgenerative mitral Regurgitation: rationale and design of the mitral FINDER study.Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction.Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling : Ready for prime time?Fast, precise, and accurate myocardial T1 mapping using a radial MOLLI sequence with FLASH readout.Myocardial T1 Measurement Predicts Beneficial LV Remodeling After Long-Term Heart Failure Therapy.Diffuse myocardial fibrosis among healthy pediatric heart transplant recipients: Correlation of histology, cardiovascular magnetic resonance, and clinical phenotype.Novel Imaging of Hypoglycemia-induced Myocardial Abnormality by Cardiac Magnetic Resonance T1-mapping.Myocardial Extracellular Volume Quantification by Cardiovascular Magnetic Resonance and Computed Tomography.Cardiac extracellular matrix is associated with adverse outcome in patients with chronic heart failure.Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation.Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping.
P2860
Q26744817-EA7DE054-90B2-4AF9-8E74-095EDA1AAA09Q33168755-293CADCA-EF23-45D1-BBBF-E00110C207EAQ36220925-F4495B19-5298-47A6-83E2-F7CE409C5B7BQ37278457-4CD52637-2C8A-4065-94CF-0F699ECF1B69Q37579150-F30B290D-6131-4A0A-94C2-E949F0B3470FQ38413105-5A878241-8AAC-47BA-85FB-E8C77D5A572EQ38642910-12B46B35-0E48-4089-A966-E14834E7626AQ38671622-C6B17641-EC44-4D36-8476-20C50D22C9B7Q38935425-D3C9C599-6BAE-48BF-AEF8-7601B7361BEEQ38980504-2764A36B-A0D1-474D-8C8A-2648BEC17629Q39210161-8CA943BB-1049-4996-856C-83B23D5D1967Q39388903-CF4F29A3-90C2-44C8-90AA-3C31335A0D4DQ40081734-906D96B4-DD16-4DD8-9437-0EDE4A16E874Q41692607-159A2293-2B5D-43A9-832D-EBAEB48B19C2Q42373017-694C14C1-0E84-431D-827E-5F610C47949CQ47116847-A35F7979-D7CE-47A9-AB90-440B78775E37Q47297387-C7519D7F-B728-4C74-BF45-8AE9C224AFE1Q47619369-C205A915-38B7-4C2A-8A58-8AAA1F119386Q47780168-1C929092-7618-4C32-A04C-CF9EAC7DA840Q48016282-E726FDFE-859A-4E30-8FCD-FEFAF1053F9AQ48337289-F7590C8E-8DA2-4467-9E7E-FDE865FA839FQ49233984-B418363D-EE66-49AD-9533-80C507915F2BQ52670629-10758A40-8E7C-4DE7-B805-AEA36490284BQ52819862-850FABE7-19D8-494E-A7A5-E6A3157A5204Q52877004-58B573C9-9D87-4F68-888F-A04FA31FD1F1Q55055776-5EA911A1-7BBC-48A9-B0CF-B456681B3549Q55494001-11BA9587-74E9-4905-AB11-9963D628EC5F
P2860
T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication.
@en
type
label
T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication.
@en
prefLabel
T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication.
@en
P2093
P1476
T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication.
@en
P2093
Alina Bachmann
Andreas Greiser
Beatrice A Marzluf
Caroline Zotter-Tufaro
Diana Bonderman
Franz Duca
Irene M Lang
Klaus Knechtelsdorfer
Matthias Wiesinger
Stefan Aschauer
P356
10.1016/J.JCMG.2015.11.002
P577
2015-12-06T00:00:00Z